We rank companies based on fund manager, research analyst and news sentiment
AHCO stock icon

AdaptHealth
AHCO

$9.6
17.24%
 

About: AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.

Employees: 10,700

0
Funds holding %
of 6,474 funds
0
Analysts bullish %
of 7 analysts
0
News positive %
of 9 articles

Fund manager confidence

Based on 2023 Q4 SEC filings by fund managers ($100M+ AUM)

471% more call options, than puts

Call options by funds: $2.42M | Put options by funds: $423K

25% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 59

1% less funds holding

Funds holding: 189 [Q3] → 188 (-1) [Q4]

0.62% less ownership

Funds ownership: 83.29% [Q3] → 82.67% (-0.62%) [Q4]

3% less first-time investments, than exits

New positions opened: 32 | Existing positions closed: 33

20% less capital invested

Capital invested by funds: $1.03B [Q3] → $822M (-$210M) [Q4]

25% less funds holding in top 10

Funds holding in top 10: 4 [Q3] → 3 (-1) [Q4]

Research analyst outlook

7 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$6.5
32%
downside
Avg. target
$11.21
17%
upside
High target
$13
35%
upside

7 analyst ratings

positive
86%
neutral
0%
negative
14%
RBC Capital
Ben Hendrix
35%upside
$13
Outperform
Reiterated
4 Mar 2024
UBS
Whit Mayo
35%upside
$13
Buy
Maintained
28 Feb 2024
Truist Securities
David Macdonald
35%upside
$13
Buy
Maintained
28 Feb 2024
UBS
Whit Mayo
6%downside
$9
Buy
Maintained
29 Jan 2024
RBC Capital
Ben Hendrix
35%upside
$13
Outperform
Maintained
8 Nov 2023

Financial journalist opinion

Based on 9 articles about AHCO published over the past 30 days